Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apellis Pharmaceuticals (APLS) Gains from Investment Securities (2020 - 2025)

Apellis Pharmaceuticals filings provide 6 years of Gains from Investment Securities readings, the most recent being -$6.4 million for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities fell 43073.33% year-over-year to -$6.4 million, compared with a TTM value of -$179000.0 through Dec 2025, down 414.04%, and an annual FY2025 reading of $9.1 million, up 12.61% over the prior year.
  • Gains from Investment Securities hit -$6.4 million in Q4 2025 for Apellis Pharmaceuticals, down from $6.4 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $11.2 million in Q4 2021, with the low at -$21.4 million in Q4 2022.
  • Median Gains from Investment Securities over the past 5 years was $264000.0 (2023), compared with a mean of -$802466.4.
  • The sharpest move saw Gains from Investment Securities skyrocketed 430800.0% in 2021, then tumbled 43073.33% in 2025.
  • Year by year, Gains from Investment Securities stood at $11.2 million in 2021, then tumbled by 290.94% to -$21.4 million in 2022, then soared by 114.51% to $3.1 million in 2023, then crashed by 99.52% to $15000.0 in 2024, then plummeted by 43073.33% to -$6.4 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at -$6.4 million, $6.4 million, and $495672.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.